Secondly, BNP peptides are already powerful tools to stratify HF patients, so that it could be difficult to improve significantly the clinical meaning in a small population or in a real-life population: only class III patient for instance should have been included to get a more specific population with better predefined endpoints, and a long follow-up. Here, NPPB is linked to hydrops fetalis.